Elsevier

European Journal of Cancer

Volume 82, September 2017, Pages 167-170
European Journal of Cancer

Letter to the Editor
Recurrent bowel obstruction: unusual presentation of pembrolizumab-induced pancreatitis in annular pancreas

https://doi.org/10.1016/j.ejca.2017.05.042Get rights and content

Section snippets

Conflict of interest statement

None declared.

References (22)

  • C. Robert et al.

    Pembrolizumab versus ipilimumab in advanced melanoma

    N Engl J Med

    (2015)
  • Cited by (0)

    View full text